Nickolay Kukekov Founder of KalGene Pharmaceuticals Backed byChenel CapitalChenel Capital PartnersRichard Chenel LinkedIn SourcesKalGene Pharmaceuticals, Inc. announces a new peer-review publication demonstrating the efficacy of KG207 in clearing toxic oligomer species of amyloid beta in translational imaging studies — 2021-05 Browse all founders · Browse investors
